Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Combining 5% minoxidil and 0.5% anthralin can help regrow hair in some severe alopecia areata patients.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Nail problems are common in people with alopecia areata, often leading to cosmetic and functional issues, but more research is needed for treatment guidelines.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Injecting platelet-rich plasma is a safe and effective way to treat hair loss.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Sulfasalazine may help treat persistent alopecia areata.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

"20-nail dystrophy" can have multiple causes.

New genetic discoveries in alopecia areata could lead to better treatments.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Alefacept does not effectively treat severe alopecia areata.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.